Wyeth, McNeil Strike Swiftly With Ads After Vioxx Recall
This article was originally published in The Tan Sheet
Executive Summary
Wyeth Consumer Health and McNeil are capitalizing on concerns generated by Merck's recall of its prescription pain reliever Vioxx with ads for Advil (ibuprofen) and Tylenol (acetaminophen)
You may also be interested in...
OTC Ads’ Vioxx Comparisons Communicate “Options,” Pitts Says
OTC analgesic ads comparing the pain relievers to Vioxx (rofecoxib) do not cross the boundary of propriety, according to Peter Pitts, senior VP-health affairs at the public relations firm Manning, Selvage & Lee (New York)
OTC Ads’ Vioxx Comparisons Communicate “Options,” Pitts Says
OTC analgesic ads comparing the pain relievers to Vioxx (rofecoxib) do not cross the boundary of propriety, according to Peter Pitts, senior VP-health affairs at the public relations firm Manning, Selvage & Lee (New York)
OTC Ads’ Vioxx Comparisons Communicate “Options,” Pitts Says
OTC analgesic ads comparing the pain relievers to Vioxx (rofecoxib) do not cross the boundary of propriety, according to Peter Pitts, senior VP-health affairs at the public relations firm Manning, Selvage & Lee (New York)